Nicotine and metabolites in meconium as evidence of maternal cigarette smoking during pregnancy and predictors of neonatal growth deficits

Nicotine and Tobacco Research

Volumn 12, Issue 6, 2010, Pages 658-664

  Gray, Teresa R ^a   Eiden, Rina D ^b   Leonard, Kenneth E ^b   Connors, Gerard ^b   Shisler, Shannon ^b   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b RESEARCH INSTITUTE ON ADDICTIONS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; COTININE; NICOTINE; TRANS 3' HYDROXYCOTININE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BIRTH WEIGHT; CONTROLLED STUDY; FEMALE; GESTATIONAL AGE; GROWTH RETARDATION; HEAD CIRCUMFERENCE; HUMAN; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; MATERNAL SMOKING; MECONIUM; MULTIPLE DRUG ABUSE; PREVALENCE; PRIORITY JOURNAL; SELF REPORT; TANDEM MASS SPECTROMETRY; THIRD TRIMESTER PREGNANCY;

ADOLESCENT; ADULT; CHROMATOGRAPHY, LIQUID; COTININE; FEMALE; HUMANS; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; MECONIUM; NICOTINE; PREGNANCY; PREGNANCY TRIMESTERS; SMOKING; TANDEM MASS SPECTROMETRY; YOUNG ADULT;

EID: 77955260697     PISSN: 14622203     EISSN: 1469994X     Source Type: Journal    
DOI: 10.1093/ntr/ntq068     Document Type: Article

References (30)

1. Baranowski, J., Pochopien, G., & Baranowska, I. (1998). Determination of nicotine, cotinine and caffeine in meconium using high-performance liquid chromatography. Journal of Chromatography B: Biomedical Sciences and Applications, 707, 317-321.
2. Benowitz, N. L., Jacob, P., III., Ahjevych, K., Jarvis, M. J., Hall, S., LeHouezec, J., et al. (2002). Biochemical verification of tobacco use and cessation. Nicotine & Tobacco Research, 4, 149-159.
3. Boyd, N. R., Windsor, R. A., Perkins, L. L., & Lowe, J. B. (1998). Quality of measurement of smoking status by self-report and saliva cotinine among pregnant women. Maternal and Child Health Journal, 2, 77-83.
4. Britton, G. R. A., Brinthaupt, J., Stehle, J., & James, G. (2004). Comparison of self-reported smoking and urinary cotinine levels in a rural pregnant population. Journal of Obstetric, Gynecologic, and Neonatal Nursing, 33, 306-311.
5. England, L. J., Grauman, A., Qian, C., Wilkins, D. G., Schisterman, E. F., Yu, K. F., et al. (2007). Misclassification of maternal smoking status and its effects on an epidemiologic study of pregnancy outcomes. Nicotine & Tobacco Research, 9, 1005-1013.
6. Etzel, R. A. (1990). A review of the use of saliva cotinine as a marker of tobacco smoke exposure. Preventive Medicine, 19, 190-197.
7. Florescu, A., Ferrence, R., Einarson, T., Selby, P., Soldin, O., & Koren, G. (2009). Methods for quantification of exposure to cigarette smoking and environmental tobacco smoke: Focus on developmental toxicology. Therapeutic Drug Monitoring, 31, 14-30.
8. Gray, T., & Huestis, M. (2007). Bioanalytical procedures for monitoring in utero drug exposure. Analytical and Bioanalytical Chemistry, 388, 1455-1465.
9. Gray, T. R., LaGasse, L. L., Smith, L. M., Derauf, C., Grant, P., Shah, R., et al. (2009). Identification of prenatal amphetamines exposure by maternal interview and meconium toxicology in the Infant Development, Environment and Lifestyle (IDEAL) Study. Therapeutic Drug Monitoring, 31, 769-775.
10. Gray, T. R., Magri, R., Shakleya, D. M., & Huestis, M. A. (2008). Meconium nicotine and metabolites by liquid chromatographytandem mass spectrometry: differentiation of passive and nonexposure and correlation with neonatal outcome measures. Clinical Chemistry, 54, 2018-2027.
11. Gray, T. R., Shakleya, D. M., & Huestis, M. A. (2008). Quantification of nicotine, cotinine, trans-3′-hydroxycotinine, nornicotine and norcotinine in human meconium by liquid chromatography tandem mass spectrometry. Journal of Chromatography B, 863, 107-114.
12. Gray, T. R., Shakleya, D. M., & Huestis, M. A. (2009). A liquid chromatography tandem mass spectrometry method for the simultaneous quantification of 20 drugs of abuse and metabolites in human meconium. Analytical and Bioanalytical Chemistry, 393, 1977-1990.
13. Hegaard, H. K., Kjaergaard, H., Moller, L. F., Wachmann, H., & Ottesen, B. (2007). Determination of a saliva cotinine cut-off to distinguish pregnant smokers from pregnant non-smokers. Acta Obstetricia et Gynecologica Scandinavica, 86, 401-406.
14. Herrmann, M., King, K., & Weitzman, M. (2008). Prenatal tobacco smoke and postnatal secondhand smoke exposure and child neurodevelopment. Current Opinion in Pediatrics, 20, 184-190.
15. Kacinko, S. L., Jones, H. E., Johnson, R. E., Choo, R. E., & Huestis, M. A. (2008). Correlations of maternal buprenorphine dose, buprenorphine, and metabolite concentrations in meconium with neonatal outcomes. Clinical Pharmacology and Therapeutics, 84, 604-612.
16. Kohler, E., Avenarius, S., Rabsilber, A., Gerloff, C., & Jorch, G. (2007). Assessment of prenatal tobacco smoke exposure by determining nicotine and its metabolites in meconium. Human and Experimental Toxicology, 26, 535-544.
17. Magnusson, A., Gransson, M., & Heilig, M. (2005). Unexpectedly high prevalence of alcohol use among pregnant Swedish women: Failed detection by antenatal care and simple tools that improve detection. Journal of Studies on Alcohol, 66, 157-164.
18. Markovic, N., Ness, R. B., Cefilli, D., Grisso, J. A., Stahmer, S., & Shaw, L. M. (2000). Substance use measures among women in early pregnancy. American Journal of Obstetrics and Gynecology, 183, 627-632.
19. Ostrea, E., Villanueva-Uy, E., Ngerncham, S., Punnakanta, L., Batilando, M. J. P., Agarwal, P., et al. (2008). An epidemiologic study comparing fetal exposure to tobacco smoke in three Southeast Asian countries. International Journal of Occupational and Environmental Health, 14, 257-262.
20. Ostrea, E. M., Knapp, D. K., Romero, A. I., Montes, M., & Ostrea, A. R. (1994). Meconium analysis to assess fetal exposure to nicotine by active and passive maternal smoking. Journal of Pediatrics, 124, 471-476.
21. Owen, L., & McNeill, A. (2001). Saliva cotinine as indicator of cigarette smoking in pregnant women. Addiction, 96, 1001-1006.
22. Parazzini, F., Davoli, E., Rabaiotti, M., Restelli, S., Stramare, L., Dindelli, M., et al. (1996). Validity of self-reported smoking habits in pregnancy: A saliva cotinine analysis. Acta Obstetricia et Gynecologica Scandinavica, 75, 352-354.
23. Sarkar, M., Burnett, M., Carrire, S., Cox, L., Dell, C., Gammon, H., et al. (2009). Screening and recording of alcohol use among women of child-bearing age and pregnant women. Canadian Journal of Clinical Pharmacology, 16, e242-e263.
24. Sherif, N. A., Kamel, S. M., Al-Ashkar, O. S., Sharaki, O. A., Seif, E. A., & Hegazy, E. A. (2004). Detection of cotinine in neonate meconium as a marker for nicotine exposure in utero. Eastern Mediterranean Health Journal, 10, 96-105.
25. Sobell, L. C., & Sobell, M. B. (1992). Timeline follow-back. A technique for assessing self-reported alcohol consumption. In R. Litten & J. Allen (Eds.), Measuring alcohol consumption (pp. 41-73), Totowa, NJ: Humana Press.
26. Sobell, L. C., Sobell, M. B., Leo, G. I., & Cancilla, A. (1988). Reliability of a timeline method: Assessing normal drinkers′ reports of recent drinking and a comparative evaluation across several populations. British Journal of Addiction, 83, 393-402.
27. Substance Abuse and Mental Health Services Administration. (2009). Results from the 2008 National Survey on Drug Use and Health: National findings (No. DHHS Publication No. SMA 09-4434). Rockville, MD: Department of Health and Human Services.
28. U.S. Department of Health and Human Services. (2004a). Chapter 5. Reproductive effects. In J. M. Samet, L. A. Norman & C. Wilbanks (Eds.), The health consequences of smoking: A report of the Surgeon General. (pp. 550-601). Atlanta, GA: U.S. Government Printing Office.
29. U.S. Department of Health and Human Services. (2004b). Chapter 7: The impact of smoking on disease and the benefits on smoking reduction. In J. M. Samet, L. A. Norman & C. Wilbanks (Eds.), The health consequences of smoking: A report of the Surgeon General (pp. 853-93), Atlanta, GA: U.S. Government Printing Office.
30. Webb, D., Boyd, N., Messina, D., & Windsor, R. (2003). The discrepancy between self-reported smoking status and urine cotinine levels among women enrolled in prenatal care at four publicly funded clinical sites. Journal of Public Health Management and Practice, 9, 322-325.